Status:
COMPLETED
Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia
Lead Sponsor:
Jessa Hospital
Conditions:
COVID 19
Eligibility:
All Genders
18+ years
Brief Summary
Descriptive prospective study to investigate the prevalence of COVID 19 during ambulant screening
Detailed Description
The exact prevalence of COVID-19 is unknown. Due to the relatively high number of diagnosed, symptomatic infections despite a strict policy, we expect a high prevalence of COVID 19 throughout the enti...
Eligibility Criteria
Inclusion
- All adult patients \> 18 years scheduled for a (semi) urgent surgery, hematological or oncological treatment or elektrophysiciological investigations in the Jessa hospital
Exclusion
- Patients \< 18 years
- Adult patients who are unable the give informed consent
- Language barrier
Key Trial Info
Start Date :
April 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2020
Estimated Enrollment :
528 Patients enrolled
Trial Details
Trial ID
NCT04334252
Start Date
April 17 2020
End Date
December 20 2020
Last Update
January 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa hospital
Hasselt, Belgium, 3500